Patents and seed industry

October 22, 2016 01:16 am | Updated December 02, 2016 10:47 am IST

Indian IP laws, which are TRIPS compliant, make it clear that seeds and plants or parts thereof cannot be patented. Therefore, the article, “ > The battle over Bt cotton ” (Oct.4), is misleading. This provision is a result of India opting to provide sui genesis legislation that provides intellectual property protection for plant varieties including transgenic varieties under a separate and specialised law known as the Protection of Plant Varieties and Farmers’ Rights (PPVFR) Act, 2001. Monsanto’s patents on Bt cotton genes and methods of transformation of cotton do not have any claims directed on seeds, plants or parts thereof. Had the writer examined the claims made by Monsanto while seeking the registration of patents under the Patent Cooperation Treaty in India from the Controller of Patents, Patents Office, Chennai, he would have found a rejection of most claims whenever there is a mention of plants, seeds or plant tissues.

When the government enacted the Cotton Seeds Price (Control) Order and subsequently notified the “licensing guidelines and formats for GM technology licensing agreements”, Monsanto ran a misinformed campaign that the Agriculture Ministry had wrongly invoked the provisions of compulsory licensing of the Patent Act. Even if the Bollgard-I gene was patented in India like Bollgard-II, Monsanto would not have been able to have any rights on seeds and plant varieties. On the other hand, Section 26 of the PPVFR Act provides a right to them to make a claim before the PPVFR Authority for benefit sharing based on the agronomic value the Bollgard trait confers to various new varieties developed by breeders. It is wrong to apply the provisions of the Patent Act to transgenic varieties. As clarified by the government in the IPR Policy 2016, only the PPVFR Act, 2001 governs IP rights for transgenic varieties.

The National Seed Association of India has asked the Ministry of Agriculture to implement the PPVFR Act without any distortion. If TRIPS- compliant IP laws are implemented, Monsanto will have the right to claim the trait value under Section 26 of the PPVFR Act. However, they will not have the power to unilaterally determine the trait value which they have been doing so since 2002. This can result in a huge drop in their profitability, which has resulted in the campaign.

Breeders have the right to use even a protected variety with a transgenic trait to develop new varieties and commercialise them under Section 30. Farmers have the rights to save, resow, barter or sell without branding the seeds of even a protected transgenic variety. It is important to ensure such a balance as there is a likelihood of several GM traits being approved in all major food crops such as rice, wheat, mustard and corn.

Threats by Monsanto to withdraw from India are not real as even at a Rs.49 trait value per packet, as fixed by the government for 2016, Monsanto makes a revenue of Rs.200 crore on a single GM trait.

M. Prabhakar Rao,

President, National Seed Association of India,


Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.